Atrium Therapeutics, Inc.
RNANasdaqCIK 2093101HealthcareFiscal year ends Dec 31
Reports and events: 9 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0906:17 ET | 8-K/A | 8.01 Other events | 0001193125-26-418417 |
| 2026-10-0806:52 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-417402 |
| 2026-08-1316:51 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349488 |
| 2026-08-1316:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349482 |
| 2026-07-1417:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-303393 |
| 2026-05-1416:51 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-224243 |
| 2026-05-1416:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-224238 |
| 2026-02-2717:22 ET | 8-K | 1.01 Entry into a material agreement; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-083227 |
| 2026-02-2616:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-077105 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 08:57 ET. Listed shows no prices and gives no investment advice.